Maintaining an Efficient and Safe Cell Therapy Supply Chain

In this whitepaper, Dr. Matthew Lakelin, TrakCel’s VP Scientific Affairs discusses the complexities of an Autologous Therapy supply chain and some of the key areas that need to be considered for a therapy developer in addressing these challenges.

    Download Content

    Please let us know where you heard about TrakCel*

    Preview of PDF download